Literature DB >> 19071625

Turbulent flow and ternary column-switching on-line clean-up system for high-throughput quantification of risperidone and its main metabolite in plasma by LC-MS/MS: application to a bioequivalence study.

Constantinos Kousoulos1, Yannis Dotsikas, Yannis L Loukas.   

Abstract

A high-throughput LC-MS/MS method was developed for the simultaneous determination of Risperidone and 9-OH-risperidone in human plasma. A semi-automated sample preparation procedure was applied, including protein precipitation after addition of ACN, via a robotic system, and subsequent sub-zero temperature extraction of the latter. Injections of the ACN extractants were performed on a turbulent flow ternary column-switching system, consisted of dual extraction columns in parallel for on-line purification of samples and an analytical column. Toggling with the assistance of two valves provided a run cycle time of 3 min and the whole procedure minimized carry-over effect. On-line clean-up procedure along with sub-zero temperature extraction increased sample purification and extended column life. The analytical range of the method was 0.1-200 ng mL(-1) for both analytes with excellent linearity and very good accuracy and precision. The proposed method was employed in a bioequivalence study after per os administration of a 2mg tablet of risperidone and allowed the completion of the study (>1400 samples) in only 4 days time.

Entities:  

Year:  2006        PMID: 19071625     DOI: 10.1016/j.talanta.2006.10.049

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  2 in total

1.  Determination of risperidone in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study in Chinese volunteers.

Authors:  Ming-zhu Huang; Jian-zhong Shentu; Jun-chun Chen; Jian Liu; Hui-li Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2008-02       Impact factor: 3.066

2.  Use of the Charge Transfer Reactions for the Spectrophotometric Determination of Risperidone in Pure and in Dosage Forms.

Authors:  Hemavathi Nagaraju Deepakumari; Hosakere Doddarevanna Revanasiddappa
Journal:  J Pharm (Cairo)       Date:  2012-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.